Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-07-17The Pharmacokinetics and Safety of Ritonavir-boosted Indinavir 600/100mg Bid Combined With NRTIs in ARV naïve HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2020-07-17A Pilot Study of the Pharmacokinetics and Safety of Lopinavir/Ritonavir 400/100mg Bid Versus Lopinavir/Ritonavir 600/150 mg BID Combined With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2020-06-30Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months for Tuberculosis Preventive Treatment: A Randomized Controlled Study in China
-
CLINICAL_TRIALS study record update · 2020-06-29A Prospective Cohort Study on the Effect of Latent Infection of Tuberculosis on the Pregnancy Outcome of IVF-ET in Infertile Patients With Radiographic Lesions Suggesting Old Healed Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-05-06A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-04-29The Role of Interferon Gamma Releasing Assays (IGRA) in Screening and Monitoring for Tuberculosis During Anti-TNF Therapy in Patients With Immune-mediated Inflammatory Disease (IMID)
-
CLINICAL_TRIALS study record update · 2020-04-13Open-label Prospective Noncomparative Study of Safety, Tolerability and Pharmacokinetics of PBTZ169 After Single and Multiple Fasting Oral Administration in Increasing Doses in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-03-31Randomized Evaluation of a Conditional Cash Transfer Program for Routine Immunizations of Infants in Nigeria
-
CLINICAL_TRIALS study record update · 2020-03-27The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia: a Therapeutic Drug Monitoring (TDM) Approach
-
CLINICAL_TRIALS study record update · 2020-03-24Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi
-
CLINICAL_TRIALS study record update · 2020-03-24Acceptability and Completion Rates of a New 12 Dose Treatment (3 Month) Compared to the Standard Treatment for Latent TB Infection Treatment
-
CLINICAL_TRIALS study record update · 2020-03-19AIDS Defining Opportunistic Infections in Naive HIV Cases
-
CLINICAL_TRIALS study record update · 2020-03-18Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation: a National Multicenter Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-03-09Multicenter, Open, Randomized Study With Active Control to Evaluate the Early Bactericidal Activity, Safety and Pharmacokinetics of the Drug PBTZ169 When Used in Patients With First-diagnosed Tuberculosis of the Respiratory System With Bacterial Excretion and Saved Bacterial Susceptibility to Isoniazid and Rifampicin
-
CLINICAL_TRIALS study record update · 2020-03-04Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases
-
CLINICAL_TRIALS study record update · 2020-02-28Clinical Trial to Investigate the Appropriate Dose of Isoniazid According to NAT2 Polymorphism Status in Korean Subjects
-
CLINICAL_TRIALS study record update · 2020-02-18Innovative Approach in Tuberculosis Care in Armenia
-
CLINICAL_TRIALS study record update · 2020-02-12A Pilot Study of the Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly With Lopinavir/Ritonavir Based HAART in HIV/TB Co-infected Patients
-
CLINICAL_TRIALS study record update · 2020-02-06LILAC - TB : Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset : a Proof of Concept Study in Cambodia and Ivory Coast (ANRS 12394)
-
CLINICAL_TRIALS study record update · 2020-02-05Service Development: Assessing Non-attendance Rates in Outpatient Clinics
-
CLINICAL_TRIALS study record update · 2020-01-29A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, Among Participants Taking Multidrug Treatment for Drug-Resistant Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-01-27Phase I Open-Label Dose Escalation Trial for the Development of a Human BCG Challenge Model for Assessment of TB Immunity
-
CLINICAL_TRIALS study record update · 2020-01-27SMS-based Mobile Health Intervention for Nutritional Status and Treatment Outcomes Among TB Patients in Addis Ababa, Ethiopia: A Cluster Randomized Trial (CRT)
-
CLINICAL_TRIALS study record update · 2019-12-17Pilot Study to Estimate the Potential Efficacy and Safety of Using Adjunctive Ibuprofen for the Treatment of XDR Tuberculosis
-
CLINICAL_TRIALS study record update · 2019-12-11Retrospective Analysis of Tuberculosis in Rheumatic Diseases for Epidemiology, Risk Factors, Disease Presentation, Complications, Treatment, and Prognosis